Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerated dose of gemcitabine
that can be given with busulfan and melphalan. The safety of this drug combination will also
be studied.